FDA Inspection
Spectra Therapy, LLC.Spectra Therapy, LLC. – FDA Inspection, Dec 1, 2017
Record Details
This FDA Inspection record concerns Spectra Therapy, LLC., with an inspection on December 1, 2017, issued by the Center for Devices and Radiological Health, covering devices.
View Company Profile
ID · c5ebde07-e2c8-401f-a37c-ee08d31faed9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1032515
- FDA center
- Medical Devices & Rad Health
- Project area
- Postmarket Assurance: Devices
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 820.80(b)Lack of or inadequate receiving acceptance procedures
- 21 CFR 820.100(a)Lack of or inadequate procedures
- 21 CFR 820.30(a)Design control - no procedures
- 21 CFR 820.198(a)Lack of or inadequate complaint procedures
- 21 CFR 820.50Purchasing controls, Lack of or inadequate procedures
- 21 CFR 803.17Lack of Written MDR Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Spectra Therapy, LLC.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 8, 2026 | Not classified | Detroit District Office | Compliance: Devices |
| September 13, 2024 | OAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
Other documents for Spectra Therapy, LLC.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.